Global leaders unite to tackle drug-resistant bacteria

Plus, news about CSL Vi­for, Ake­bia and Pan Can­cer T: Faron gets FDA go-ahead for stream­lined reg­is­tra­tional path: The com­pa­ny said the reg­u­la­tor “ac­knowl­edged the

The enFuse technology allows drug delivery of up to 25 mL. Credit: Castleski via www.shutterstock.com The US Food and Drug Administration (FDA) has approved Apellis

A new im­munother­a­py biotech from famed Johns Hop­kins on­col­o­gy re­searchers Bert Vo­gel­stein and Drew Par­doll is in the works, with a siz­able $153 mil­lion fi­nanc­ing